These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24465008)

  • 1. Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas.
    Fong D; Seeber A; Terracciano L; Kasal A; Mazzoleni G; Lehne F; Gastl G; Spizzo G
    J Clin Pathol; 2014 May; 67(5):408-14. PubMed ID: 24465008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer.
    Fong D; Moser P; Kasal A; Seeber A; Gastl G; Martowicz A; Wurm M; Mian C; Obrist P; Mazzoleni G; Spizzo G
    Histopathology; 2014 Apr; 64(5):683-92. PubMed ID: 24117877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominant expression of truncated EpCAM is associated with a more aggressive phenotype and predicts poor overall survival in colorectal cancer.
    Seeber A; Untergasser G; Spizzo G; Terracciano L; Lugli A; Kasal A; Kocher F; Steiner N; Mazzoleni G; Gastl G; Fong D
    Int J Cancer; 2016 Aug; 139(3):657-63. PubMed ID: 26996277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis.
    Warneke VS; Behrens HM; Haag J; Krüger S; Simon E; Mathiak M; Ebert MP; Röcken C
    Br J Cancer; 2013 Oct; 109(8):2217-27. PubMed ID: 24008668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases.
    Cimino A; Halushka M; Illei P; Wu X; Sukumar S; Argani P
    Breast Cancer Res Treat; 2010 Oct; 123(3):701-8. PubMed ID: 20012351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of nuclear EpICD in extrahepatic cholangiocarcinoma: association with β-catenin.
    Jachin S; Bae JS; Sung JJ; Park HS; Jang KY; Chung MJ; Kim DG; Moon WS
    Int J Oncol; 2014 Aug; 45(2):691-8. PubMed ID: 24888903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial Cell Adhesion Molecule in Primary Sjögren's Syndrome Patients: Characterization and Evaluation of a Potential Biomarker.
    Zhang K; Zhou Y; Cheng X; Fu X; Du W; Feng Y; Jia J; Yang X; Xiao G; Zheng Z; Zhu P; Wu Z
    J Immunol Res; 2019; 2019():3269475. PubMed ID: 31886299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
    Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
    BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells.
    Liang KH; Tso HC; Hung SH; Kuan II; Lai JK; Ke FY; Chuang YT; Liu IJ; Wang YP; Chen RH; Wu HC
    Cancer Lett; 2018 Oct; 433():165-175. PubMed ID: 29981429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear signalling by tumour-associated antigen EpCAM.
    Maetzel D; Denzel S; Mack B; Canis M; Went P; Benk M; Kieu C; Papior P; Baeuerle PA; Munz M; Gires O
    Nat Cell Biol; 2009 Feb; 11(2):162-71. PubMed ID: 19136966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear EpICD expression and its role in hepatocellular carcinoma.
    Park SY; Bae JS; Cha EJ; Chu HH; Sohn JS; Moon WS
    Oncol Rep; 2016 Jul; 36(1):197-204. PubMed ID: 27176150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.
    Kunavisarut T; Kak I; Macmillan C; Ralhan R; Walfish PG
    BMC Cancer; 2012 Nov; 12():523. PubMed ID: 23153310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma.
    Umemori K; Ono K; Eguchi T; Kawai H; Nakamura T; Ogawa T; Yoshida K; Kanemoto H; Sato K; Obata K; Ryumon S; Yutori H; Katase N; Okui T; Nagatsuka H; Ibaragi S
    Oral Oncol; 2023 Jul; 142():106433. PubMed ID: 37236125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder.
    Brunner A; Prelog M; Verdorfer I; Tzankov A; Mikuz G; Ensinger C
    J Clin Pathol; 2008 Mar; 61(3):307-10. PubMed ID: 17586680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial activation of EpCAM cleavage via cell-to-cell contact.
    Denzel S; Maetzel D; Mack B; Eggert C; Bärr G; Gires O
    BMC Cancer; 2009 Nov; 9():402. PubMed ID: 19925656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression.
    Panda SS; Lee CC; Geevimaan K; Chen KC; Yang SH; Shen CN; HuangFu WC; Wu HC
    J Biomed Sci; 2024 Jul; 31(1):72. PubMed ID: 39010070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis.
    Ralhan R; Cao J; Lim T; Macmillan C; Freeman JL; Walfish PG
    BMC Cancer; 2010 Jun; 10():331. PubMed ID: 20579375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis.
    Spizzo G; Fong D; Wurm M; Ensinger C; Obrist P; Hofer C; Mazzoleni G; Gastl G; Went P
    J Clin Pathol; 2011 May; 64(5):415-20. PubMed ID: 21415054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers.
    Ralhan R; He HC; So AK; Tripathi SC; Kumar M; Hasan MR; Kaur J; Kashat L; MacMillan C; Chauhan SS; Freeman JL; Walfish PG
    PLoS One; 2010 Nov; 5(11):e14130. PubMed ID: 21152431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
    Yanamoto S; Kawasaki G; Yoshitomi I; Iwamoto T; Hirata K; Mizuno A
    Oral Oncol; 2007 Oct; 43(9):869-77. PubMed ID: 17207659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.